pharmaobservatory 0.1.7 → 0.1.8
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +83 -4
- data/docs/BiomarkerAlleleFrequenciesResponse.md +58 -0
- data/docs/BiomarkerAlleleFrequenciesRow.md +62 -0
- data/docs/BiomarkerAssayProvidersResponse.md +58 -0
- data/docs/BiomarkerAssayProvidersRow.md +72 -0
- data/docs/BiomarkerEvidenceByYearResponse.md +58 -0
- data/docs/BiomarkerEvidenceByYearRow.md +32 -0
- data/docs/BiomarkerTraversalStatusResponse.md +58 -0
- data/docs/BiomarkerTraversalStatusRow.md +36 -0
- data/docs/BiomarkersApi.md +320 -0
- data/docs/CompaniesApi.md +1001 -99
- data/docs/CompanyAssetsRow.md +5 -1
- data/docs/CompanyBiomarkerCapabilityResponse.md +58 -0
- data/docs/CompanyBiomarkerCapabilityRow.md +68 -0
- data/docs/CompanyProgramsRow.md +5 -1
- data/docs/CompanyRareDiseaseDeclarationsResponse.md +58 -0
- data/docs/CompanyRareDiseaseDeclarationsRow.md +52 -0
- data/docs/GxpFacilitiesRow.md +22 -0
- data/docs/LegalEntitiesApi.md +981 -101
- data/docs/LegalEntitiesRecordAttributes.md +6 -0
- data/docs/LegalEntitySecFilingsResponse.md +58 -0
- data/docs/LegalEntitySecFilingsRow.md +44 -0
- data/docs/OrgDisclosureTrendResponse.md +58 -0
- data/docs/OrgDisclosureTrendRow.md +62 -0
- data/docs/OwnershipSourceCoverageResponse.md +58 -0
- data/docs/OwnershipSourceCoverageRow.md +62 -0
- data/docs/ProgramLicensingCandidatesRow.md +5 -1
- data/docs/ProgramsRow.md +1 -1
- data/docs/RwdConductorDeliveryResponse.md +58 -0
- data/docs/RwdConductorDeliveryRow.md +74 -0
- data/docs/RwdConductorFootprintResponse.md +58 -0
- data/docs/RwdConductorFootprintRow.md +40 -0
- data/docs/RwdConductorStudiesResponse.md +58 -0
- data/docs/RwdConductorStudiesRow.md +42 -0
- data/docs/RwdConductorsApi.md +393 -0
- data/docs/RwdConductorsRecord.md +38 -0
- data/docs/RwdConductorsResponse.md +58 -0
- data/docs/RwdConductorsRow.md +72 -0
- data/docs/RwdInstitutionsApi.md +153 -0
- data/docs/RwdInstitutionsRecord.md +38 -0
- data/docs/RwdInstitutionsResponse.md +58 -0
- data/docs/RwdInstitutionsRow.md +154 -0
- data/docs/RwdNetworksApi.md +153 -0
- data/docs/RwdNetworksRecord.md +38 -0
- data/docs/RwdNetworksResponse.md +58 -0
- data/docs/RwdNetworksRow.md +110 -0
- data/docs/RwdStudiesApi.md +80 -0
- data/docs/SbtiCrosscheckResponse.md +58 -0
- data/docs/SbtiCrosscheckRow.md +48 -0
- data/docs/SponsorDeliveryResponse.md +58 -0
- data/docs/SponsorDeliveryRow.md +52 -0
- data/docs/SponsorPatentMentionsResponse.md +58 -0
- data/docs/SponsorPatentMentionsRow.md +42 -0
- data/docs/SponsorTrialConditionsResponse.md +58 -0
- data/docs/SponsorTrialConditionsRow.md +36 -0
- data/docs/SponsorTrialDrugsResponse.md +58 -0
- data/docs/SponsorTrialDrugsRow.md +34 -0
- data/lib/pharmaobservatory/api/biomarkers_api.rb +336 -0
- data/lib/pharmaobservatory/api/companies_api.rb +1131 -130
- data/lib/pharmaobservatory/api/legal_entities_api.rb +1047 -123
- data/lib/pharmaobservatory/api/rwd_conductors_api.rb +413 -0
- data/lib/pharmaobservatory/api/rwd_institutions_api.rb +161 -0
- data/lib/pharmaobservatory/api/rwd_networks_api.rb +161 -0
- data/lib/pharmaobservatory/api/rwd_studies_api.rb +84 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_row.rb +465 -0
- data/lib/pharmaobservatory/models/biomarker_assay_providers_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_assay_providers_row.rb +520 -0
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_row.rb +300 -0
- data/lib/pharmaobservatory/models/biomarker_traversal_status_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_traversal_status_row.rb +322 -0
- data/lib/pharmaobservatory/models/company_assets_row.rb +24 -2
- data/lib/pharmaobservatory/models/company_biomarker_capability_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_biomarker_capability_row.rb +498 -0
- data/lib/pharmaobservatory/models/company_programs_row.rb +24 -2
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_row.rb +410 -0
- data/lib/pharmaobservatory/models/gxp_facilities_row.rb +122 -1
- data/lib/pharmaobservatory/models/legal_entities_record_attributes.rb +28 -1
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_response.rb +478 -0
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_row.rb +370 -0
- data/lib/pharmaobservatory/models/org_disclosure_trend_response.rb +478 -0
- data/lib/pharmaobservatory/models/org_disclosure_trend_row.rb +465 -0
- data/lib/pharmaobservatory/models/ownership_source_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_source_coverage_row.rb +465 -0
- data/lib/pharmaobservatory/models/program_licensing_candidates_row.rb +24 -2
- data/lib/pharmaobservatory/models/programs_row.rb +1 -1
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_row.rb +537 -0
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_row.rb +346 -0
- data/lib/pharmaobservatory/models/rwd_conductor_studies_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_studies_row.rb +355 -0
- data/lib/pharmaobservatory/models/rwd_conductors_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_conductors_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductors_row.rb +526 -0
- data/lib/pharmaobservatory/models/rwd_institutions_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_institutions_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_institutions_row.rb +981 -0
- data/lib/pharmaobservatory/models/rwd_networks_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_networks_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_networks_row.rb +733 -0
- data/lib/pharmaobservatory/models/sbti_crosscheck_response.rb +478 -0
- data/lib/pharmaobservatory/models/sbti_crosscheck_row.rb +388 -0
- data/lib/pharmaobservatory/models/sponsor_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_delivery_row.rb +410 -0
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_row.rb +355 -0
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_row.rb +322 -0
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_row.rb +311 -0
- data/lib/pharmaobservatory/version.rb +1 -1
- data/lib/pharmaobservatory.rb +46 -0
- metadata +94 -2
metadata
CHANGED
|
@@ -1,14 +1,14 @@
|
|
|
1
1
|
--- !ruby/object:Gem::Specification
|
|
2
2
|
name: pharmaobservatory
|
|
3
3
|
version: !ruby/object:Gem::Version
|
|
4
|
-
version: 0.1.
|
|
4
|
+
version: 0.1.8
|
|
5
5
|
platform: ruby
|
|
6
6
|
authors:
|
|
7
7
|
- Scientist.com
|
|
8
8
|
autorequire:
|
|
9
9
|
bindir: bin
|
|
10
10
|
cert_chain: []
|
|
11
|
-
date: 2026-10-
|
|
11
|
+
date: 2026-10-23 00:00:00.000000000 Z
|
|
12
12
|
dependencies:
|
|
13
13
|
- !ruby/object:Gem::Dependency
|
|
14
14
|
name: faraday
|
|
@@ -94,17 +94,23 @@ files:
|
|
|
94
94
|
- docs/ApiV1WhoamiGet200ResponseQuotaBuckets.md
|
|
95
95
|
- docs/ApiV1WhoamiGet200ResponseQuotaBucketsRequestsPerMinute.md
|
|
96
96
|
- docs/AuthError.md
|
|
97
|
+
- docs/BiomarkerAlleleFrequenciesResponse.md
|
|
98
|
+
- docs/BiomarkerAlleleFrequenciesRow.md
|
|
97
99
|
- docs/BiomarkerAssayEvidenceResponse.md
|
|
98
100
|
- docs/BiomarkerAssayEvidenceResponseBuild.md
|
|
99
101
|
- docs/BiomarkerAssayEvidenceResponseFreshness.md
|
|
100
102
|
- docs/BiomarkerAssayEvidenceResponseScope.md
|
|
101
103
|
- docs/BiomarkerAssayEvidenceRow.md
|
|
104
|
+
- docs/BiomarkerAssayProvidersResponse.md
|
|
105
|
+
- docs/BiomarkerAssayProvidersRow.md
|
|
102
106
|
- docs/BiomarkerAssayWhitespaceResponse.md
|
|
103
107
|
- docs/BiomarkerAssayWhitespaceRow.md
|
|
104
108
|
- docs/BiomarkerBqpAssertionsResponse.md
|
|
105
109
|
- docs/BiomarkerBqpAssertionsRow.md
|
|
106
110
|
- docs/BiomarkerCdxAssertionsResponse.md
|
|
107
111
|
- docs/BiomarkerCdxAssertionsRow.md
|
|
112
|
+
- docs/BiomarkerEvidenceByYearResponse.md
|
|
113
|
+
- docs/BiomarkerEvidenceByYearRow.md
|
|
108
114
|
- docs/BiomarkerEvidenceResponse.md
|
|
109
115
|
- docs/BiomarkerEvidenceRow.md
|
|
110
116
|
- docs/BiomarkerLiteratureResponse.md
|
|
@@ -117,6 +123,8 @@ files:
|
|
|
117
123
|
- docs/BiomarkerSampleCoverageRow.md
|
|
118
124
|
- docs/BiomarkerSamplePrevalenceResponse.md
|
|
119
125
|
- docs/BiomarkerSamplePrevalenceRow.md
|
|
126
|
+
- docs/BiomarkerTraversalStatusResponse.md
|
|
127
|
+
- docs/BiomarkerTraversalStatusRow.md
|
|
120
128
|
- docs/BiomarkerValidationResponse.md
|
|
121
129
|
- docs/BiomarkerValidationRow.md
|
|
122
130
|
- docs/BiomarkerVariantMentionsResponse.md
|
|
@@ -144,6 +152,8 @@ files:
|
|
|
144
152
|
- docs/CompaniesRow.md
|
|
145
153
|
- docs/CompanyAssetsResponse.md
|
|
146
154
|
- docs/CompanyAssetsRow.md
|
|
155
|
+
- docs/CompanyBiomarkerCapabilityResponse.md
|
|
156
|
+
- docs/CompanyBiomarkerCapabilityRow.md
|
|
147
157
|
- docs/CompanyFundingEventsResponse.md
|
|
148
158
|
- docs/CompanyFundingEventsRow.md
|
|
149
159
|
- docs/CompanyFundingSummaryResponse.md
|
|
@@ -152,6 +162,8 @@ files:
|
|
|
152
162
|
- docs/CompanyMembersRow.md
|
|
153
163
|
- docs/CompanyProgramsResponse.md
|
|
154
164
|
- docs/CompanyProgramsRow.md
|
|
165
|
+
- docs/CompanyRareDiseaseDeclarationsResponse.md
|
|
166
|
+
- docs/CompanyRareDiseaseDeclarationsRow.md
|
|
155
167
|
- docs/CompanyTargetsResponse.md
|
|
156
168
|
- docs/CompanyTargetsRow.md
|
|
157
169
|
- docs/CompanyTrialGeographyResponse.md
|
|
@@ -276,10 +288,14 @@ files:
|
|
|
276
288
|
- docs/LegalEntitiesRecordAttributes.md
|
|
277
289
|
- docs/LegalEntitiesResponse.md
|
|
278
290
|
- docs/LegalEntitiesRow.md
|
|
291
|
+
- docs/LegalEntitySecFilingsResponse.md
|
|
292
|
+
- docs/LegalEntitySecFilingsRow.md
|
|
279
293
|
- docs/ManagersApi.md
|
|
280
294
|
- docs/ManagersRecord.md
|
|
281
295
|
- docs/ManagersResponse.md
|
|
282
296
|
- docs/ManagersRow.md
|
|
297
|
+
- docs/OrgDisclosureTrendResponse.md
|
|
298
|
+
- docs/OrgDisclosureTrendRow.md
|
|
283
299
|
- docs/OrgDisclosuresResponse.md
|
|
284
300
|
- docs/OrgDisclosuresRow.md
|
|
285
301
|
- docs/OrgRelationshipsResponse.md
|
|
@@ -288,6 +304,8 @@ files:
|
|
|
288
304
|
- docs/OwnershipPercentagesRow.md
|
|
289
305
|
- docs/OwnershipPositionsResponse.md
|
|
290
306
|
- docs/OwnershipPositionsRow.md
|
|
307
|
+
- docs/OwnershipSourceCoverageResponse.md
|
|
308
|
+
- docs/OwnershipSourceCoverageRow.md
|
|
291
309
|
- docs/PdufaDatesResponse.md
|
|
292
310
|
- docs/PdufaDatesRow.md
|
|
293
311
|
- docs/ProgramLicensingCandidatesResponse.md
|
|
@@ -337,8 +355,26 @@ files:
|
|
|
337
355
|
- docs/RecallsResponse.md
|
|
338
356
|
- docs/RecallsRow.md
|
|
339
357
|
- docs/ResultPage.md
|
|
358
|
+
- docs/RwdConductorDeliveryResponse.md
|
|
359
|
+
- docs/RwdConductorDeliveryRow.md
|
|
360
|
+
- docs/RwdConductorFootprintResponse.md
|
|
361
|
+
- docs/RwdConductorFootprintRow.md
|
|
362
|
+
- docs/RwdConductorStudiesResponse.md
|
|
363
|
+
- docs/RwdConductorStudiesRow.md
|
|
364
|
+
- docs/RwdConductorsApi.md
|
|
365
|
+
- docs/RwdConductorsRecord.md
|
|
366
|
+
- docs/RwdConductorsResponse.md
|
|
367
|
+
- docs/RwdConductorsRow.md
|
|
340
368
|
- docs/RwdCoverageResponse.md
|
|
341
369
|
- docs/RwdCoverageRow.md
|
|
370
|
+
- docs/RwdInstitutionsApi.md
|
|
371
|
+
- docs/RwdInstitutionsRecord.md
|
|
372
|
+
- docs/RwdInstitutionsResponse.md
|
|
373
|
+
- docs/RwdInstitutionsRow.md
|
|
374
|
+
- docs/RwdNetworksApi.md
|
|
375
|
+
- docs/RwdNetworksRecord.md
|
|
376
|
+
- docs/RwdNetworksResponse.md
|
|
377
|
+
- docs/RwdNetworksRow.md
|
|
342
378
|
- docs/RwdRegisterProvenanceResponse.md
|
|
343
379
|
- docs/RwdRegisterProvenanceRow.md
|
|
344
380
|
- docs/RwdRegistersApi.md
|
|
@@ -373,6 +409,8 @@ files:
|
|
|
373
409
|
- docs/RwdStudyMilestonesRow.md
|
|
374
410
|
- docs/RwdWithheldFieldsResponse.md
|
|
375
411
|
- docs/RwdWithheldFieldsRow.md
|
|
412
|
+
- docs/SbtiCrosscheckResponse.md
|
|
413
|
+
- docs/SbtiCrosscheckRow.md
|
|
376
414
|
- docs/SecPdufaDatesResponse.md
|
|
377
415
|
- docs/SecPdufaDatesRow.md
|
|
378
416
|
- docs/SiteBedsYearlyResponse.md
|
|
@@ -394,10 +432,18 @@ files:
|
|
|
394
432
|
- docs/SitesRecordAttributes.md
|
|
395
433
|
- docs/SitesResponse.md
|
|
396
434
|
- docs/SitesRow.md
|
|
435
|
+
- docs/SponsorDeliveryResponse.md
|
|
436
|
+
- docs/SponsorDeliveryRow.md
|
|
437
|
+
- docs/SponsorPatentMentionsResponse.md
|
|
438
|
+
- docs/SponsorPatentMentionsRow.md
|
|
397
439
|
- docs/SponsorRecruitmentByPhaseResponse.md
|
|
398
440
|
- docs/SponsorRecruitmentByPhaseRow.md
|
|
399
441
|
- docs/SponsorRecruitmentDurationResponse.md
|
|
400
442
|
- docs/SponsorRecruitmentDurationRow.md
|
|
443
|
+
- docs/SponsorTrialConditionsResponse.md
|
|
444
|
+
- docs/SponsorTrialConditionsRow.md
|
|
445
|
+
- docs/SponsorTrialDrugsResponse.md
|
|
446
|
+
- docs/SponsorTrialDrugsRow.md
|
|
401
447
|
- docs/SponsorTrialStartForecastResponse.md
|
|
402
448
|
- docs/SponsorTrialStartForecastRow.md
|
|
403
449
|
- docs/SponsorTrialsResponse.md
|
|
@@ -487,6 +533,9 @@ files:
|
|
|
487
533
|
- lib/pharmaobservatory/api/managers_api.rb
|
|
488
534
|
- lib/pharmaobservatory/api/query_api.rb
|
|
489
535
|
- lib/pharmaobservatory/api/rare_diseases_api.rb
|
|
536
|
+
- lib/pharmaobservatory/api/rwd_conductors_api.rb
|
|
537
|
+
- lib/pharmaobservatory/api/rwd_institutions_api.rb
|
|
538
|
+
- lib/pharmaobservatory/api/rwd_networks_api.rb
|
|
490
539
|
- lib/pharmaobservatory/api/rwd_registers_api.rb
|
|
491
540
|
- lib/pharmaobservatory/api/rwd_sources_api.rb
|
|
492
541
|
- lib/pharmaobservatory/api/rwd_studies_api.rb
|
|
@@ -503,17 +552,23 @@ files:
|
|
|
503
552
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets.rb
|
|
504
553
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets_requests_per_minute.rb
|
|
505
554
|
- lib/pharmaobservatory/models/auth_error.rb
|
|
555
|
+
- lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb
|
|
556
|
+
- lib/pharmaobservatory/models/biomarker_allele_frequencies_row.rb
|
|
506
557
|
- lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb
|
|
507
558
|
- lib/pharmaobservatory/models/biomarker_assay_evidence_response_build.rb
|
|
508
559
|
- lib/pharmaobservatory/models/biomarker_assay_evidence_response_freshness.rb
|
|
509
560
|
- lib/pharmaobservatory/models/biomarker_assay_evidence_response_scope.rb
|
|
510
561
|
- lib/pharmaobservatory/models/biomarker_assay_evidence_row.rb
|
|
562
|
+
- lib/pharmaobservatory/models/biomarker_assay_providers_response.rb
|
|
563
|
+
- lib/pharmaobservatory/models/biomarker_assay_providers_row.rb
|
|
511
564
|
- lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb
|
|
512
565
|
- lib/pharmaobservatory/models/biomarker_assay_whitespace_row.rb
|
|
513
566
|
- lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb
|
|
514
567
|
- lib/pharmaobservatory/models/biomarker_bqp_assertions_row.rb
|
|
515
568
|
- lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb
|
|
516
569
|
- lib/pharmaobservatory/models/biomarker_cdx_assertions_row.rb
|
|
570
|
+
- lib/pharmaobservatory/models/biomarker_evidence_by_year_response.rb
|
|
571
|
+
- lib/pharmaobservatory/models/biomarker_evidence_by_year_row.rb
|
|
517
572
|
- lib/pharmaobservatory/models/biomarker_evidence_response.rb
|
|
518
573
|
- lib/pharmaobservatory/models/biomarker_evidence_row.rb
|
|
519
574
|
- lib/pharmaobservatory/models/biomarker_literature_response.rb
|
|
@@ -526,6 +581,8 @@ files:
|
|
|
526
581
|
- lib/pharmaobservatory/models/biomarker_sample_coverage_row.rb
|
|
527
582
|
- lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb
|
|
528
583
|
- lib/pharmaobservatory/models/biomarker_sample_prevalence_row.rb
|
|
584
|
+
- lib/pharmaobservatory/models/biomarker_traversal_status_response.rb
|
|
585
|
+
- lib/pharmaobservatory/models/biomarker_traversal_status_row.rb
|
|
529
586
|
- lib/pharmaobservatory/models/biomarker_validation_response.rb
|
|
530
587
|
- lib/pharmaobservatory/models/biomarker_validation_row.rb
|
|
531
588
|
- lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb
|
|
@@ -550,6 +607,8 @@ files:
|
|
|
550
607
|
- lib/pharmaobservatory/models/companies_row.rb
|
|
551
608
|
- lib/pharmaobservatory/models/company_assets_response.rb
|
|
552
609
|
- lib/pharmaobservatory/models/company_assets_row.rb
|
|
610
|
+
- lib/pharmaobservatory/models/company_biomarker_capability_response.rb
|
|
611
|
+
- lib/pharmaobservatory/models/company_biomarker_capability_row.rb
|
|
553
612
|
- lib/pharmaobservatory/models/company_funding_events_response.rb
|
|
554
613
|
- lib/pharmaobservatory/models/company_funding_events_row.rb
|
|
555
614
|
- lib/pharmaobservatory/models/company_funding_summary_response.rb
|
|
@@ -558,6 +617,8 @@ files:
|
|
|
558
617
|
- lib/pharmaobservatory/models/company_members_row.rb
|
|
559
618
|
- lib/pharmaobservatory/models/company_programs_response.rb
|
|
560
619
|
- lib/pharmaobservatory/models/company_programs_row.rb
|
|
620
|
+
- lib/pharmaobservatory/models/company_rare_disease_declarations_response.rb
|
|
621
|
+
- lib/pharmaobservatory/models/company_rare_disease_declarations_row.rb
|
|
561
622
|
- lib/pharmaobservatory/models/company_targets_response.rb
|
|
562
623
|
- lib/pharmaobservatory/models/company_targets_row.rb
|
|
563
624
|
- lib/pharmaobservatory/models/company_trial_geography_response.rb
|
|
@@ -676,9 +737,13 @@ files:
|
|
|
676
737
|
- lib/pharmaobservatory/models/legal_entities_record_attributes.rb
|
|
677
738
|
- lib/pharmaobservatory/models/legal_entities_response.rb
|
|
678
739
|
- lib/pharmaobservatory/models/legal_entities_row.rb
|
|
740
|
+
- lib/pharmaobservatory/models/legal_entity_sec_filings_response.rb
|
|
741
|
+
- lib/pharmaobservatory/models/legal_entity_sec_filings_row.rb
|
|
679
742
|
- lib/pharmaobservatory/models/managers_record.rb
|
|
680
743
|
- lib/pharmaobservatory/models/managers_response.rb
|
|
681
744
|
- lib/pharmaobservatory/models/managers_row.rb
|
|
745
|
+
- lib/pharmaobservatory/models/org_disclosure_trend_response.rb
|
|
746
|
+
- lib/pharmaobservatory/models/org_disclosure_trend_row.rb
|
|
682
747
|
- lib/pharmaobservatory/models/org_disclosures_response.rb
|
|
683
748
|
- lib/pharmaobservatory/models/org_disclosures_row.rb
|
|
684
749
|
- lib/pharmaobservatory/models/org_relationships_response.rb
|
|
@@ -687,6 +752,8 @@ files:
|
|
|
687
752
|
- lib/pharmaobservatory/models/ownership_percentages_row.rb
|
|
688
753
|
- lib/pharmaobservatory/models/ownership_positions_response.rb
|
|
689
754
|
- lib/pharmaobservatory/models/ownership_positions_row.rb
|
|
755
|
+
- lib/pharmaobservatory/models/ownership_source_coverage_response.rb
|
|
756
|
+
- lib/pharmaobservatory/models/ownership_source_coverage_row.rb
|
|
690
757
|
- lib/pharmaobservatory/models/pdufa_dates_response.rb
|
|
691
758
|
- lib/pharmaobservatory/models/pdufa_dates_row.rb
|
|
692
759
|
- lib/pharmaobservatory/models/program_licensing_candidates_response.rb
|
|
@@ -734,8 +801,23 @@ files:
|
|
|
734
801
|
- lib/pharmaobservatory/models/recalls_response.rb
|
|
735
802
|
- lib/pharmaobservatory/models/recalls_row.rb
|
|
736
803
|
- lib/pharmaobservatory/models/result_page.rb
|
|
804
|
+
- lib/pharmaobservatory/models/rwd_conductor_delivery_response.rb
|
|
805
|
+
- lib/pharmaobservatory/models/rwd_conductor_delivery_row.rb
|
|
806
|
+
- lib/pharmaobservatory/models/rwd_conductor_footprint_response.rb
|
|
807
|
+
- lib/pharmaobservatory/models/rwd_conductor_footprint_row.rb
|
|
808
|
+
- lib/pharmaobservatory/models/rwd_conductor_studies_response.rb
|
|
809
|
+
- lib/pharmaobservatory/models/rwd_conductor_studies_row.rb
|
|
810
|
+
- lib/pharmaobservatory/models/rwd_conductors_record.rb
|
|
811
|
+
- lib/pharmaobservatory/models/rwd_conductors_response.rb
|
|
812
|
+
- lib/pharmaobservatory/models/rwd_conductors_row.rb
|
|
737
813
|
- lib/pharmaobservatory/models/rwd_coverage_response.rb
|
|
738
814
|
- lib/pharmaobservatory/models/rwd_coverage_row.rb
|
|
815
|
+
- lib/pharmaobservatory/models/rwd_institutions_record.rb
|
|
816
|
+
- lib/pharmaobservatory/models/rwd_institutions_response.rb
|
|
817
|
+
- lib/pharmaobservatory/models/rwd_institutions_row.rb
|
|
818
|
+
- lib/pharmaobservatory/models/rwd_networks_record.rb
|
|
819
|
+
- lib/pharmaobservatory/models/rwd_networks_response.rb
|
|
820
|
+
- lib/pharmaobservatory/models/rwd_networks_row.rb
|
|
739
821
|
- lib/pharmaobservatory/models/rwd_register_provenance_response.rb
|
|
740
822
|
- lib/pharmaobservatory/models/rwd_register_provenance_row.rb
|
|
741
823
|
- lib/pharmaobservatory/models/rwd_registers_record.rb
|
|
@@ -767,6 +849,8 @@ files:
|
|
|
767
849
|
- lib/pharmaobservatory/models/rwd_study_milestones_row.rb
|
|
768
850
|
- lib/pharmaobservatory/models/rwd_withheld_fields_response.rb
|
|
769
851
|
- lib/pharmaobservatory/models/rwd_withheld_fields_row.rb
|
|
852
|
+
- lib/pharmaobservatory/models/sbti_crosscheck_response.rb
|
|
853
|
+
- lib/pharmaobservatory/models/sbti_crosscheck_row.rb
|
|
770
854
|
- lib/pharmaobservatory/models/sec_pdufa_dates_response.rb
|
|
771
855
|
- lib/pharmaobservatory/models/sec_pdufa_dates_row.rb
|
|
772
856
|
- lib/pharmaobservatory/models/site_beds_yearly_response.rb
|
|
@@ -787,10 +871,18 @@ files:
|
|
|
787
871
|
- lib/pharmaobservatory/models/sites_record_attributes.rb
|
|
788
872
|
- lib/pharmaobservatory/models/sites_response.rb
|
|
789
873
|
- lib/pharmaobservatory/models/sites_row.rb
|
|
874
|
+
- lib/pharmaobservatory/models/sponsor_delivery_response.rb
|
|
875
|
+
- lib/pharmaobservatory/models/sponsor_delivery_row.rb
|
|
876
|
+
- lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb
|
|
877
|
+
- lib/pharmaobservatory/models/sponsor_patent_mentions_row.rb
|
|
790
878
|
- lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb
|
|
791
879
|
- lib/pharmaobservatory/models/sponsor_recruitment_by_phase_row.rb
|
|
792
880
|
- lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb
|
|
793
881
|
- lib/pharmaobservatory/models/sponsor_recruitment_duration_row.rb
|
|
882
|
+
- lib/pharmaobservatory/models/sponsor_trial_conditions_response.rb
|
|
883
|
+
- lib/pharmaobservatory/models/sponsor_trial_conditions_row.rb
|
|
884
|
+
- lib/pharmaobservatory/models/sponsor_trial_drugs_response.rb
|
|
885
|
+
- lib/pharmaobservatory/models/sponsor_trial_drugs_row.rb
|
|
794
886
|
- lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb
|
|
795
887
|
- lib/pharmaobservatory/models/sponsor_trial_start_forecast_row.rb
|
|
796
888
|
- lib/pharmaobservatory/models/sponsor_trials_response.rb
|